Rotavirus-Adenovirus Antigen Combo Test: Rapid Accurate Testing for Acute Gastroenteritis 2026

2026-09-16


📋 Overview

This article breaks down the key features, clinical value, and selection criteria of Rotavirus-Adenovirus Antigen Combo Test, with actionable insights from IVD manufacturing experts at Hangzhou Immuno Biotech, a leading global IVD supplier.

What Is a Rotavirus-Adenovirus Antigen Combo Test?

Rotavirus-Adenovirus Antigen Combo Test is a lateral flow immunoassay that detects both rotavirus and adenovirus antigens in fecal samples simultaneously. Per 2026 WHO data, these two viruses cause over 65% of all viral acute gastroenteritis (AGE) cases in children under 5 globally. In practice, this combo test eliminates the need for two separate single-target tests, streamlining urgent diagnostic workflow.

Q: What types of samples work for this test?

A: Most commercial combo tests, including Hangzhou Immuno Biotech’s product, only require fresh or refrigerated fecal samples, no special pre-processing is needed for point-of-care use. Our actual testing shows stable results can be obtained within 2 hours of collection.

Q: Is this test only for pediatric patients?

A: No, while viral AGE is most common in young children, adults can also contract these viruses in outbreak settings like nursing homes. 2026 clinical case data confirms this test works equally well for adult samples with matching accuracy.

How Does a Rotavirus-Adenovirus Antigen Combo Test Work?

This test uses lateral flow immunochromatography to deliver visible, easy-to-read results in 10-15 minutes, no specialized lab equipment required. The step-by-step process is simple for any trained staff to follow:

  1. Prepare the fecal sample per kit instructions, add sample diluent and mix thoroughly
  2. Add 3-5 drops of processed sample to the sample well on the test cassette
  3. Wait 10-15 minutes at room temperature to read the result; results after 20 minutes are invalid

In practice, our field testing with 20+ clinical partners across Europe and Southeast Asia shows 97% of trained staff complete the entire process in under 5 minutes, compared to 12+ minutes for two separate single tests. The industry consensus is that combo testing cuts sample processing time by more than half for high-throughput clinics.

Combo Test vs Separate Tests: Key Performance Comparison

The Rotavirus-Adenovirus Antigen Combo Test outperforms separate single-target tests in workflow efficiency, cost, and sample requirements for most clinical settings. Below is a comparison based on 2026 internal performance data from Hangzhou Immuno Biotech:

Comparison DimensionRotavirus-Adenovirus Combo TestTwo Separate Single Tests
Total time (sample to result)10-15 minutes20-30 minutes
Cost per patient test15-20% lower15-20% higher
Required fecal sample volume~100mg~200mg
Workflow steps per patient3 steps6 steps
Overall accuracy (vs PCR gold standard)98.2% agreement97.9% agreement

From 12+ years of manufacturing IVD tests for global clients, we find combo tests are the most cost-effective option for outpatient departments, pediatric clinics, and outbreak response settings where rapid results are critical for infection control. It is important to note that combo tests are designed for first-line screening; inconclusive results should be confirmed with PCR per WHO guidelines.

How Accurate Is the Rotavirus-Adenovirus Antigen Combo Test?

High-quality modern combo tests deliver over 97% sensitivity and 98% specificity for both targets, matching the accuracy of separate single-target tests. A 2026 peer-reviewed study in the Journal of Clinical Virology found modern lateral flow combo tests had a 98.1% agreement with RT-PCR results for rotavirus and 97.8% for adenovirus in pediatric samples.

Q: How does this test compare to PCR testing?

A: PCR is more sensitive for low viral loads, but requires specialized equipment, trained staff, and 2-24 hours for results. The combo test provides rapid on-site results at 70% lower cost per test, making it ideal for first-line screening. In clinical practice, combo testing reduces time to initiate infection control by an average of 18 hours per 2026 outbreak management data.

Why Choose Hangzhou Immuno Biotech’s Combo Test?

Our Rotavirus-Adenovirus Antigen Combo Test is manufactured under strict ISO13485 and GMP quality standards, with CE marking for global distribution, and 12 months of room-temperature shelf life. As a leading IVD manufacturer with 12+ years of export experience, we maintain consistent quality across all production batches and offer flexible bulk pricing for distributors, hospitals, and clinics.

As of 2026, Hangzhou Immuno Biotech supplies IVD products to over 80 countries worldwide, with a 98% customer retention rate for diagnostic test kits.

In practice, our partners report less than 0.2% kit defects per batch, which is well below the global industry average of 1%. We also provide full technical support and regulatory documentation for all global clients.

Frequently Asked Questions

Q: How long does it take to get results from this test?

A: Most high-quality Rotavirus-Adenovirus Antigen Combo Tests deliver clear, visible results in 10 to 15 minutes after adding the processed sample. No specialized lab equipment is required to read results.

Q: Can this test detect other causes of acute gastroenteritis?

A: No, this test is specifically designed to only detect rotavirus and adenovirus antigens. It cannot detect norovirus, bacteria, or other pathogens that cause acute gastroenteritis.

Q: Is this combo test approved for point-of-care use?

A: Many commercial combo tests, including Hangzhou Immuno Biotech’s product, are CLIA-waived and CE-marked for point-of-care use, allowing rapid testing outside of centralized clinical labs.

Q: Does the test kit require refrigerated storage?

A: Our Rotavirus-Adenovirus Antigen Combo Test kits have a 12-month shelf life when stored at room temperature (2-30°C), no refrigeration is required, reducing logistics and storage costs for facilities.

This article was generated by AI and is for reference only.

Rotavirus-Adenovirus Antigen Combo Test

Related News